Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.Unknown journal · 2026-05-25Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06Psilocybin Attenuates Cortical Representations of Aversion in the Mouse Auditory CortexbioRxiv · 2026-03-26Psilocybin or Nicotine Patch for Smoking CessationJAMA Network Open · 2026-03-09Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).Professional Psychology Research and Practice · 2026-01-31Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21Is there more to magic mushrooms than psilocybin?C&EN Global Enterprise · 2025-10-19Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.Unknown journal · 2025-09-30Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World ReligionsPsychedelic Medicine · 2025-05-15Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.Unknown journal · 2025-04-22Psychedelics and substance use disorder treatment.Unknown journal · 2025-04-20186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-08Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementBMJ Open · 2025-03-31Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco AddictionDrug and Alcohol Dependence · 2025-01-31Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.Unknown journal · 2025-01-06Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional propertiesNature Mental Health · 2024-10-13Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.Unknown journal · 2024-10-02Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depressionNature Mental Health · 2024-08-04Psilocybin-assisted therapy and HIV-related shameScientific Reports · 2024-08-01Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.Unknown journal · 2024-05-30Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy PersistsAJOB Neuroscience · 2024-02-04IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.Pharmacological research · 2023-12-31Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-13Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-13Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Unknown journal · 2023-10-10Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Assessing potential of psilocybin for depressive disorders.Unknown journal · 2023-06-30Functional MRI markers for treatment-resistant depression: Insights and challenges.Progress in brain research · 2022-12-31Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.Unknown journal · 2022-05-17Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.Unknown journal · 2022-04-26Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of Psychopharmacology · 2022-01-31Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.Unknown journal · 2021-12-31Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.Frontiers in psychology · 2021-12-31Human behavioral pharmacology of psychedelics.Unknown journal · 2021-11-10Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.The international journal of neuropsychopharmacology · 2021-08-19Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.Unknown journal · 2021-07-26Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.Unknown journal · 2021-07-21Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.The American Journal of Drug and Alcohol Abuse · 2021-06-04Psychedelics and health behaviour change.Unknown journal · 2021-05-28Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-23Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.Journal of Psychopharmacology · 2021-02-19Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic TherapyPsyArXiv · 2020-12-28Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry · 2020-11-03Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphanPsychopharmacology · 2020-06-04Editorial: Hallucinogens and Entactogens: Establishing a New Class of Drugs?Frontiers in psychiatry · 2019-12-31Cessation and reduction in alcohol consumption and misuse after psychedelic use.Unknown journal · 2019-05-13Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMTPLoS ONE · 2019-04-22Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.Unknown journal · 2018-12-03Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology · 2018-07-29Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.Journal of Psychopharmacology · 2018-06-24The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.Unknown journal · 2018-06-04Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?Unknown journal · 2018-05-02T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking SmokersBiological Psychiatry · 2018-04-08Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.Psychopharmacology · 2017-11-06Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of Psychopharmacology · 2017-10-10Potential Therapeutic Effects of Psilocybin.Unknown journal · 2017-06-30Neuroticism is associated with challenging experiences with psilocybin mushrooms.Personality and Individual Differences · 2017-06-06Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settingsDrug and Alcohol Dependence · 2017-01-20Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experienceDrug and Alcohol Dependence · 2017-01-20An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Journal of Psychopharmacology · 2017-01-17Psychedelics as Medicines: An Emerging New Paradigm.Unknown journal · 2016-12-25Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of Psychopharmacology · 2016-11-30The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of Psychopharmacology · 2016-11-16Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of Psychopharmacology · 2016-08-29Long-term follow-up of psilocybin-facilitated smoking cessation.The American Journal of Drug and Alcohol Abuse · 2016-07-20Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The International Journal of Neuropsychopharmacology · 2016-07-04Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accountsDrug and Alcohol Dependence · 2015-10-31Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybinDrug and Alcohol Dependence · 2015-10-31Comparative phenomenology of psilocybin experiences in research and non-research settingsDrug and Alcohol Dependence · 2015-10-30Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.Unknown journal · 2015-10-05Psilocybin, psychological distress, and suicidality.Unknown journal · 2015-08-31Classic hallucinogens in the treatment of addictions.Unknown journal · 2015-03-13Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.Journal of psychopharmacology (Oxford, England) · 2015-02-28Can psychedelic compounds play a part in drug dependence therapy?Unknown journal · 2014-12-31Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-15The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-15Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.Journal of Psychopharmacology · 2014-09-10Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybinDrug and Alcohol Dependence · 2014-06-06Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot studyDrug and Alcohol Dependence · 2014-06-06Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.Journal of psychopharmacology (Oxford, England) · 2013-12-31Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Current Drug Abuse Reviews · 2013-12-31Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.Journal for the Scientific Study of Religion · 2012-11-30High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.Unknown journal · 2012-04-12Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Drug and Alcohol Dependence · 2011-11-28Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.Journal of Psychopharmacology · 2011-09-27Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.Psychopharmacology · 2011-06-14Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.Journal of Psychopharmacology · 2008-06-30Theoretical studies on the conformations of psilocin and mescaline.Unknown journal · 1973-08-31Theoretical studies on the conformations of psilocin and mescaline.Molecular pharmacology · 1973-08-31Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteersComprehensive Psychiatry · 1960-11-30